{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:36:12Z","timestamp":1789450572046,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Zhejiang Engineering Research Center of Innovative technologies and diagnostic and therapeutic equipment for urinary system diseases."},{"name":"the Ningbo Top Medical and Health Research Program","award":["2022020203"],"award-info":[{"award-number":["2022020203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-06003-7","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T13:33:50Z","timestamp":1761140030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The combination of prostate health index and multiparametric magnetic resonance imaging in prostate cancer diagnosis: efficacy analysis in different PSA ranges and its clinical decision-guiding value"],"prefix":"10.1007","volume":"43","author":[{"given":"Jin-feng","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-ya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-wei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-long","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"6003_CR1","first-page":"420","volume":"8","author":"JM Kocarnik","year":"2021","unstructured":"Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, Henrikson HJ, Lu D, Pennini A, Xu R, Ababneh E, Mohsen A-K, Hedayat A, Sherief A-E, Amir A, Aidin A, Hassan A, Hassan A, Isaac Akinkunmi A, Qorinah Estiningtyas Sakilah A, Shailesh A, Muhammad Sohail A, Mohammad A, Bright Opoku A, Sajjad A, Tauseef A, Ali A, Sepideh A, Tarik AR, Yusra AS, Gizachew Taddesse A, Addis A, Tayyaba A, Chisom Joyqueenet A, Hanadi AH, Fares A, Ziyad A-A, Saqib A, Yousef A, Vahid A, Syed Mohamed A, Motasem A, Amir A-H, Nihad A, Sadeq Ali Ali A-M, Sami A, Nivaldo A, Nelson A-G, Hubert A, Etsay Woldu A, Robert A, Fereshteh A, Alireza A-M, Maxwell Hubert A, Davood A, Anayochukwu Edward A, Muhammad A, Jalal A, Morteza A-Z, Olatunde A, Hany A, Timur A, Muhammad A, Al A, Judie A, Zatollah A, Mohammad AJ, Tahira A, Prince A, Avinash A, Marcel A, Atalel Fentahun A, Beatriz Paulina AQ, Temesgen A, Mohammed A, Sina A, Amirhossein AJ, Ghasem A, Ahmed A, Ashish B, Saeed B, Atif Amin B, Jennifer B, Senthilkumar B, Maciej B, Till Winfried B, Francesco B-A, Fabio B, Amadou B, Masoud B, UzmaIqbal B, Woldesellassie B, Mequanint M, Yihienew Mequanint B, Devidas B, Akshaya Srikanth B, Nikha B, Pankaj B, Sonu B, Krittika B, Vijayalakshmi B et al (2021) Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol 8:420\u2013444","journal-title":"JAMA Oncol"},{"key":"6003_CR2","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","volume":"71","author":"P Cornford","year":"2017","unstructured":"Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T, Henry A, Joniau S, Lam T, Mason M, van der Poel H, van der Kwast T, Rouvi\u00e8re O, Wiegel T, Mottet N (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol 71:630\u2013642","journal-title":"Eur Urol"},{"key":"6003_CR3","doi-asserted-by":"publisher","first-page":"6244","DOI":"10.1021\/acsomega.2c05487","volume":"8","author":"LE Prestagiacomo","year":"2023","unstructured":"Prestagiacomo LE, Tradigo G, Aracri F, Gabriele C, Rota MA, Alba S, Gaspari M (2023) Data-independent acquisition mass spectrometry of EPS-urine coupled to machine learning: a predictive model for prostate cancer. ACS Omega 8:6244\u20136252","journal-title":"ACS Omega"},{"key":"6003_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/bju.15153","volume":"126","author":"PC Albertsen","year":"2020","unstructured":"Albertsen PC (2020) Prostate cancer screening and treatment: where have we come from and where are we going? BJU Int 126:218\u2013224","journal-title":"BJU Int"},{"key":"6003_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41391-017-0024-7","volume":"21","author":"T Nordstr\u00f6m","year":"2018","unstructured":"Nordstr\u00f6m T, Akre O, Aly M, Gr\u00f6nberg H, Eklund M (2018) Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer. Prostate Cancer Prostatic Dis 21:57\u201363","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6003_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","volume":"64","author":"S Loeb","year":"2013","unstructured":"Loeb S, Vellekoop A, Ahmed H, Catto J, Emberton M, Nam R, Rosario D, Scattoni V, Lotan Y (2013) Systematic review of complications of prostate biopsy. Eur Urol 64:876\u2013892","journal-title":"Eur Urol"},{"key":"6003_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.eururo.2015.02.042","volume":"68","author":"C Buzzoni","year":"2015","unstructured":"Buzzoni C, Auvinen A, Roobol M, Carlsson S, Moss S, Puliti D, de Koning H, Bangma C, Denis L, Kwiatkowski M, Lujan M, Nelen V, Paez A, Randazzo M, Rebillard X, Tammela T, Villers A, Hugosson J, Schr\u00f6der F, Zappa M (2015) Metastatic prostate cancer incidence and prostate-specific antigen testing: new insights from the European Randomized Study of Screening for Prostate Cancer. Eur Urol 68:885\u2013890","journal-title":"Eur Urol"},{"key":"6003_CR8","volume":"33","author":"F Cantiello","year":"2015","unstructured":"Cantiello F, Russo G, Ferro M, Cicione A, Cimino S, Favilla V, Perdon\u00e0 S, Bottero D, Terracciano D, De Cobelli O, Morgia G, Damiano RJUo (2015) Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy. Urol Oncol Semin Orig Investig 33:163.e15\u201323","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"6003_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1373\/clinchem.2012.195784","volume":"59","author":"C Stephan","year":"2013","unstructured":"Stephan C, Vincendeau S, Houlgatte A, Cammann H, Jung K, Semjonow A (2013) Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer. Clin Chem 59:306\u2013314","journal-title":"Clin Chem"},{"key":"6003_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041184","author":"M Ferro","year":"2020","unstructured":"Ferro M, De Cobelli O, Lucarelli G, Porreca A, Busetto G, Cantiello F, Damiano R, Autorino R, Musi G, Vartolomei M, Muto M, Terracciano D (2020) Beyond PSA: the role of prostate health index (phi). Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21041184","journal-title":"Int J Mol Sci"},{"key":"6003_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11934-019-0926-0","volume":"20","author":"P Patel","year":"2019","unstructured":"Patel P, Wang S, Siddiqui M (2019) The use of multiparametric magnetic resonance imaging (mpMRI) in the detection, evaluation, and surveillance of clinically significant prostate cancer (csPCa). Curr Urol Rep 20:60","journal-title":"Curr Urol Rep"},{"key":"6003_CR12","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko A, Borghi M, Panebianco V, Mynderse L, Vaarala M, Briganti A, Bud\u00e4us L, Hellawell G, Hindley R, Roobol M, Eggener S, Ghei M, Villers A, Bladou F, Villeirs G, Virdi J, Boxler S, Robert G, Singh P, Venderink W, Hadaschik B, Ruffion A, Hu J, Margolis D, Crouzet S, Klotz L, Taneja S, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams N, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore C (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. New Engl J Med 378:1767\u20131777","journal-title":"New Engl J Med"},{"key":"6003_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1148\/radiol.2016152827","volume":"283","author":"N Tan","year":"2017","unstructured":"Tan N, Lin W, Khoshnoodi P, Asvadi N, Yoshida J, Margolis D, Lu D, Wu H, Sung K, Lu D, Huang J, Raman SJR (2017) In-bore 3-T MR-guided transrectal targeted prostate biopsy: prostate imaging reporting and data system version 2-based diagnostic performance for detection of prostate cancer. Radiology 283:130\u2013139","journal-title":"Radiology"},{"key":"6003_CR14","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1186\/s12885-023-11306-2","volume":"23","author":"C Zongxin","year":"2023","unstructured":"Zongxin C, Jun Z, Di J, Xuedong W, Feng Q, Ximing W, Xiaojun Z, Jinxian P, Jianquan H, Yuhua H, Chen H (2023) A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score. BMC Cancer 23:1138","journal-title":"BMC Cancer"},{"key":"6003_CR15","doi-asserted-by":"publisher","first-page":"35364","DOI":"10.1038\/srep35364","volume":"6","author":"VJ Gnanapragasam","year":"2016","unstructured":"Gnanapragasam VJ, Burling K, George A, Stearn S, Warren A, Barrett T, Parker RA (2016) The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population. Sci Rep 6:35364","journal-title":"Sci Rep"},{"key":"6003_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh R, Briers E, Van den Broeck T, Cumberbatch M, De Santis M, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Grummet J, Henry A, van der Kwast T, Lam T, Lardas M, Liew M, Mason M, Moris L, Oprea-Lager D, van der Poel H, Rouvi\u00e8re O, Schoots I, Tilki D, Wiegel T, Willemse P, Cornford P (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 79:243\u2013262","journal-title":"Eur Urol"},{"key":"6003_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"E DeLong","year":"1988","unstructured":"DeLong E, DeLong D, Clarke-Pearson D (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837\u2013845","journal-title":"Biometrics"},{"key":"6003_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/bju.14916","volume":"125","author":"CC Khoo","year":"2019","unstructured":"Khoo CC, Eldred-Evans D, Peters M, Bertoncelli Tanaka M, Noureldin M, Miah S, Taimur S, Martin C, Deepika R, Martin C, Amish L, Andrea R, Feargus HJ, Emma C, Manit A, David H, Hasan Q, Mathias W, Henry T, Ahmed HU (2019) Likert vs PI-RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancer. BJU Int 125:49\u201355","journal-title":"BJU Int"},{"key":"6003_CR19","doi-asserted-by":"publisher","first-page":"e241516","DOI":"10.1001\/jamanetworkopen.2024.1516","volume":"7","author":"H Patel","year":"2024","unstructured":"Patel H, Remmers S, Ellis J, Li E, Roobol M, Fang A, Davik P, Rais-Bahrami S, Murphy A, Ross A, Gupta G (2024) Comparison of magnetic resonance imaging-based risk calculators to predict prostate cancer risk. JAMA Netw Open 7:e241516","journal-title":"JAMA Netw Open"},{"key":"6003_CR20","doi-asserted-by":"publisher","first-page":"1068893","DOI":"10.3389\/fonc.2022.1068893","volume":"12","author":"M Li-Cai","year":"2022","unstructured":"Li-Cai M, Xian-Jun Z, Hai-Hong Z, Xiao-Peng H, Lin Z, Zhi-Rui Z, Jia-Jia W (2022) Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI. Front Oncol 12:1068893","journal-title":"Front Oncol"},{"key":"6003_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/pros.24658","volume":"84","author":"H Huang","year":"2024","unstructured":"Huang H, Liu Z, Ma Y, Shao Y, Yang Z, Duan D, Zhao Y, Wen S, Tian J, Liu Y, Wang Z, Yue D, Wang Y (2024) Based on PI-RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4\u201320 ng\/mL. Prostate 84:376\u2013388","journal-title":"Prostate"},{"key":"6003_CR22","first-page":"1207","volume":"38","author":"H Po-Fan","year":"2019","unstructured":"Po-Fan H, Wei-Juan L, Wei-Ching L, Han C, Chao-Hsiang C, Chi-Ping H, Chi-Rei Y, Wen-Chi C, Yi-Huei C, Hsi-Chin W (2019) Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population. W J Urol 38:1207\u20131214","journal-title":"W J Urol"},{"key":"6003_CR23","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.eururo.2013.01.011","volume":"63","author":"M Lazzeri","year":"2013","unstructured":"Lazzeri M, Haese A, de la Taille A, Palou Redorta J, McNicholas T, Lughezzani G, Scattoni V, Bini V, Freschi M, Sussman A, Ghaleh B, Le Corvoisier P, Alberola Bou J, Esquena Fern\u00e1ndez S, Graefen M, Guazzoni G (2013) Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2\u201310 ng\/ml: a multicentric European study. Eur Urol 63:986\u2013994","journal-title":"Eur Urol"},{"key":"6003_CR24","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.juro.2010.12.032","volume":"185","author":"W Catalona","year":"2011","unstructured":"Catalona W, Partin A, Sanda M, Wei J, Klee G, Bangma C, Slawin K, Marks L, Loeb S, Broyles D, Shin S, Cruz A, Chan D, Sokoll L, Roberts W, van Schaik R, Mizrahi I (2011) A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng\/ml prostate specific antigen range. J Urol 185:1650\u20131655","journal-title":"J Urol"},{"key":"6003_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.565382","volume":"10","author":"D Huang","year":"2020","unstructured":"Huang D, Yang X, Wu Y, Lin X, Xu D, Na R, Xu J (2020) Cost-effectiveness analysis of prostate health index in decision making for initial prostate biopsy. Front Oncol 10:565382","journal-title":"Front Oncol"},{"key":"6003_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41391-020-0243-1","volume":"23","author":"J Teoh","year":"2020","unstructured":"Teoh J, Leung C, Wang M, Chiu P, Yee C, Ng C, Wong M (2020) The cost-effectiveness of prostate health index for prostate cancer detection in Chinese men. Prostate Cancer Prostat Dis 23:615\u2013621","journal-title":"Prostate Cancer Prostat Dis"},{"key":"6003_CR27","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.eururo.2013.01.011","volume":"63","author":"L Massimo","year":"2013","unstructured":"Massimo L, Alexander H, de la Taile A, Joan PR, Thomas M, Giovanni L, Vincenzo S, Vittorio B, Massimo F, Amy S, Bijan G, Philippe LC, Josep AB, Salvador EF, Markus G, Giorgio G (2013) Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2\u201310 ng\/ml: a multicentric European study. Eur Urol 63:986\u2013994","journal-title":"Eur Urol"},{"key":"6003_CR28","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.juro.2014.10.121","volume":"193","author":"S Loeb","year":"2014","unstructured":"Loeb S, Sanda MG, Broyles DL, Shin SS, Bangma CH, Wei JT, Partin AW, Klee GG, Slawin KM, Marks LS, Van Schaik RH, Daniel CW, Lori SJ, Amabelle CB, Isaac MA, William CJ (2014) The prostate health index selectively identifies clinically significant prostate cancer. J Urol 193:1163\u20131169","journal-title":"J Urol"},{"key":"6003_CR29","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.eururo.2018.10.047","volume":"75","author":"PKF Chiu","year":"2018","unstructured":"Chiu PKF, Ng CF, Semjonow A, Zhu Y, Vincendeau S, Houlgatte A, Lazzeri M, Guazzoni G, Stephan C, Haese A, Bruijne I, Jeremy Yuen-Chun T, Chi Ho L, Paola C, Chih Hung C, Lincoln Guan-Lim T, Edmund C, Chao Yuan H, Hsi Chin W, Daan N, Ding-Wei Y, Chris BH, Monique RJ (2018) A multicentre evaluation of the role of the prostate health index (PHI) in regions with differing prevalence of prostate cancer: adjustment of PHI reference ranges is needed for European and Asian settings. Eur Urol 75:558\u2013561","journal-title":"Eur Urol"},{"key":"6003_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/JCMA.0000000000000845","volume":"86","author":"H Yu-Pin","year":"2023","unstructured":"Yu-Pin H, Tzu-Ping L, Shu-Huei S, Wei-Ming C, Tzu-Hao H, I-Shen H, Yu-Hua F, Chih-Chieh L, Eric H, Hsiao-Jen C, Shing-Hwa L, Yen-Hwa C, Alex L, Huang WJ (2023) Combining prostate health index and multiparametric magnetic resonance imaging may better predict extraprostatic extension after radical prostatectomy. J Chin Med Assoc 86:52\u201356","journal-title":"J Chin Med Assoc"},{"key":"6003_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.eururo.2011.03.052","volume":"60","author":"G Guazzoni","year":"2011","unstructured":"Guazzoni G, Nava L, Lazzeri M, Scattoni V, Lughezzani G, Maccagnano C, Dorigatti F, Ceriotti F, Pontillo M, Bini V, Freschi M, Montorsi F, Rigatti P (2011) Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng\/ml: results of a prospective study in a clinical setting. Eur Urol 60:214\u2013222","journal-title":"Eur Urol"},{"key":"6003_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.juro.2015.01.091","volume":"194","author":"C de la Calle","year":"2015","unstructured":"de la Calle C, Patil D, Wei J, Scherr D, Sokoll L, Chan D, Siddiqui J, Mosquera J, Rubin M, Sanda M (2015) Multicenter evaluation of the prostate health index to detect aggressive prostate cancer in biopsy Na\u00efve Men. J Urol 194:65\u201372","journal-title":"J Urol"},{"key":"6003_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.eururo.2011.10.038","volume":"61","author":"G Guazzoni","year":"2012","unstructured":"Guazzoni G, Lazzeri M, Nava L, Lughezzani G, Larcher A, Scattoni V, Gadda G, Bini V, Cestari A, Buffi N, Freschi M, Rigatti P, Montorsi F (2012) Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer. Eur Urol 61:455\u201366","journal-title":"Eur Urol"},{"key":"6003_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/bju.15101","volume":"126","author":"Z Schwen","year":"2020","unstructured":"Schwen Z, Mamawala M, Tosoian J, Druskin S, Ross A, Sokoll L, Epstein J, Carter H, Gorin M, Pavlovich CP (2020) Prostate health index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance. BJU Int 126:373\u2013378","journal-title":"BJU Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06003-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06003-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06003-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:02:39Z","timestamp":1767999759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06003-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6003"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06003-7","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving human participants were reviewed and approved by Ethics Review Committee of The First Affiliated Hospital of Ningbo University. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"622"}}